Medical Information
Tunisia
 

This medical information website is intended only for healthcare professionals registered to practice in Tunisia.

Please choose the category that best describes you.

This content is intended only for healthcare professionals registered to practice in Tunisia.

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

Paxlovid (PF-07321332/ritonavir) does not have a Marketing Authorization. It has been granted an Emergency Use Authorization (EUA) by the Tunisia Ministry of Health for the treatment of COVID-19 in adults who do not require supplemental oxygen and who are at increased risk for progression to severe COVID-19.

PAXLOVID (PF-07321332/ritonavir)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

PAXLOVID Quick Search

Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event
Pfizer Safety

To report an adverse (event) reaction with Pfizer product, please contact Pfizer pharmacovigilance at [email protected].